LAMP1 Overexpression Predicts for Poor Prognosis in Diffuse Large B-cell Lymphoma
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 18 (11) , 749-754
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Salvianolic acid B protects hepatocytes from H2O2injury by stabilizing the lysosomal membraneWorld Journal of Gastroenterology, 2017
- Role of LAMP1 Binding and pH Sensing by the Spike Complex of Lassa VirusJournal of Virology, 2016
- B cells gone rogue: the intersection of diffuse large B cell lymphoma and autoimmune diseaseExpert Review of Hematology, 2016
- Overexpression of RBM5 induces autophagy in human lung adenocarcinoma cellsWorld Journal of Surgical Oncology, 2016
- Next-Generation Prognostic Assessment for Diffuse Large B-Cell LymphomaFuture Oncology, 2015
- Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytesHistochemistry and Cell Biology, 2014
- Surface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damageBlood, 2013
- LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicityBlood, 2013
- Diffuse Large B-Cell Lymphoma: Current Strategies and Future DirectionsCancer Control, 2012
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applicationsBlood, 2011